©The Author(s) 2026.
World J Gastroenterol. Feb 21, 2026; 32(7): 115406
Published online Feb 21, 2026. doi: 10.3748/wjg.v32.i7.115406
Published online Feb 21, 2026. doi: 10.3748/wjg.v32.i7.115406
Table 2 Univariable and multivariable Cox analyses of overall survival in the SEER cohort before and after propensity score matching
| Analysis | Characteristics | Before propensity score matching | After propensity score matching | ||
| HR (95%CI) | P value | HR (95%CI) | P value | ||
| Univariate analysis | Age | ||||
| < 50 | Reference | Reference | |||
| 50-69 | 1.77 (1.47-2.13) | < 0.001 | 1.37 (1.03-1.80) | 0.028 | |
| 70-89 | 4.41 (3.69-5.27) | < 0.001 | 3.87 (2.98-5.02) | < 0.001 | |
| ≥ 90 | 10.20 (7.93-13.1) | < 0.001 | 8.47 (5.81-12.4) | < 0.001 | |
| Gender | |||||
| Female | Reference | Reference | |||
| Male | 0.95 (0.87-1.04) | 0.292 | 0.89 (0.77-1.02) | 0.103 | |
| Race | |||||
| White | Reference | Reference | |||
| Black | 0.96 (0.78-1.17) | 0.670 | 1.02 (0.74-1.39) | 0.922 | |
| Other | 0.88 (0.76-1.02) | 0.100 | 0.69 (0.54-0.89) | 0.004 | |
| Stage | |||||
| Stage I/II | Reference | Reference | |||
| Stage III/IV | 1.48 (1.34-1.63) | < 0.001 | 1.59 (1.38-1.84) | < 0.001 | |
| Laterality | |||||
| Right side | Reference | Reference | |||
| Left side | 1.31 (1.15-1.48) | < 0.001 | 1.22 (1.05-1.41) | 0.008 | |
| Radiation | |||||
| Yes | Reference | Reference | |||
| No/unknown | 0.88 (0.74-1.04) | 0.124 | 0.98 (0.80-1.20) | 0.857 | |
| Surgery | |||||
| Yes | Reference | Reference | |||
| No | 1.19 (1.09-1.30) | < 0.001 | 1.14 (0.99-1.31) | 0.057 | |
| Chemotherapy | |||||
| Yes | Reference | Reference | |||
| No/unknown | 1.97 (1.80-2.17) | < 0.001 | 2.14 (1.86-2.46) | < 0.001 | |
| Multivariate analysis | Age | ||||
| < 50 | Reference | Reference | |||
| 50-69 | 1.76 (1.46-2.12) | < 0.001 | 1.31 (0.99-1.72) | 0.061 | |
| 70-89 | 4.14 (3.46-4.95) | < 0.001 | 3.29 (2.53-4.38) | < 0.001 | |
| ≥ 90 | 7.97 (6.15-10.31) | < 0.001 | 6.17 (4.18-9.12) | < 0.001 | |
| Stage | |||||
| Stage I/II | Reference | Reference | |||
| Stage III/IV | 1.66 (1.50-1.83) | < 0.001 | 1.67 (1.44-1.93) | < 0.001 | |
| Laterality | |||||
| Right side | Reference | Reference | |||
| Left side | 1.15 (1.01-1.31) | 0.035 | 1.16 (1.01-1.35) | 0.040 | |
| Surgery | |||||
| Yes | Reference | Reference | |||
| No | 1.26 (1.15-1.39) | < 0.001 | 1.23 (1.06-1.42) | 0.006 | |
| Chemotherapy | |||||
| Yes | Reference | Reference | |||
| No/unknown | 1.80 (1.63-1.99) | < 0.001 | 1.86 (1.60-2.17) | < 0.001 | |
- Citation: Zeng RX, Wang CQ, Yang H, Sun P, Liu PP, Wei LC, Chen TT, Wang Z, Huang H, Li ZM, Tian XP, Wang Y. Anatomical laterality of primary intestinal diffuse large B-cell lymphoma independently stratifies survival: New prognostic nomogram incorporating tumor location. World J Gastroenterol 2026; 32(7): 115406
- URL: https://www.wjgnet.com/1007-9327/full/v32/i7/115406.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i7.115406